30 C
July 24, 2024
The Hona News

Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

Respiratory syncytial virus (RSV) is one of the leading pathogens that cause lower respiratory tract infections in infants and the elderly. Passive immunoprophylaxis with monoclonal antibody (mAb) has been approved to prevent morbidity and mortality from RSV infection in infants.

Source link

Related posts

Study finds middle-aged Americans are lonelier than European counterparts


Novel genetic priority score unveiled to enhance target prioritization in drug development


Short and long sleep duration associated with blood vessel damage in those recently diagnosed with type 2 diabetes


Leave a Comment